Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic ShockKatz SD, Smilowitz NR, Hochman JS. -
Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial InfarctionR Twerenbold, JP Costabel, T Nestelberger et al.
-
No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization studyL Miao, GX Deng, RX Yin et al.
-
Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel studyB Schnorbus, A Daiber, T Gori et al.
-
Cardiac Shock Care Centers: JACC Review Topic of the WeekRab T, Ratanapo S, Kern KB et al.
-
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019DA Baran, CL Grines, S Bailey et al.
-
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart AssociationTD Henry, MI Tomey, JE Tamis-Holland et al.
-
Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological TechnologiesG Gallone, L Baldetti, G Tzanis et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
